Medical Devices & Consumables

Global DNA and RNA Oligonucleotide Synthesizers Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global DNA and RNA Oligonucleotide Synthesizers market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Danaher
K&A Labs GmbH
Biolytic Lab Performance
Thermo Fisher Scientific
BioAutomation (LGC)
Polygen GmbH
Telesis Bio
TAG Cop​​enhagen
CSBio
Kilobaser
Jiangsu Lingkun Biotechnology
Jiangsu Nanyi DiNA Digital Technology
Shanghai Yibo Biotechnology
OligoMaker
Segment by Type
Solenoid Valve Pneumatic Drive Type
Peristaltic Pump Drive Type
Segment by Application
Biopharmaceutical Companies
API Manufacturing Companies
Research Institutions
Hospital Laboratory
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the DNA and RNA Oligonucleotide Synthesizers study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to DNA and RNA Oligonucleotide Synthesizers: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global DNA and RNA Oligonucleotide Synthesizers Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Solenoid Valve Pneumatic Drive Type
1.2.3 Peristaltic Pump Drive Type
1.3 Market Segmentation by Application
1.3.1 Global DNA and RNA Oligonucleotide Synthesizers Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 API Manufacturing Companies
1.3.4 Research Institutions
1.3.5 Hospital Laboratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global DNA and RNA Oligonucleotide Synthesizers Revenue Estimates and Forecasts 2020-2031
2.2 Global DNA and RNA Oligonucleotide Synthesizers Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global DNA and RNA Oligonucleotide Synthesizers Sales Estimates and Forecasts 2020-2031
2.4 Global DNA and RNA Oligonucleotide Synthesizers Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global DNA and RNA Oligonucleotide Synthesizers Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global DNA and RNA Oligonucleotide Synthesizers Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Solenoid Valve Pneumatic Drive Type Market Size by Manufacturers
3.5.2 Peristaltic Pump Drive Type Market Size by Manufacturers
3.6 Global DNA and RNA Oligonucleotide Synthesizers Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global DNA and RNA Oligonucleotide Synthesizers Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global DNA and RNA Oligonucleotide Synthesizers Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global DNA and RNA Oligonucleotide Synthesizers Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global DNA and RNA Oligonucleotide Synthesizers Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Type (2020-2031)
6.4 North America DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America DNA and RNA Oligonucleotide Synthesizers Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Type (2020-2031)
7.4 Europe DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe DNA and RNA Oligonucleotide Synthesizers Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Type (2020-2031)
9.4 Central and South America DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America DNA and RNA Oligonucleotide Synthesizers Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa DNA and RNA Oligonucleotide Synthesizers Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa DNA and RNA Oligonucleotide Synthesizers Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Danaher
11.1.1 Danaher Corporation Information
11.1.2 Danaher Business Overview
11.1.3 Danaher DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.1.4 Danaher DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Danaher DNA and RNA Oligonucleotide Synthesizers Sales by Product in 2024
11.1.6 Danaher DNA and RNA Oligonucleotide Synthesizers Sales by Application in 2024
11.1.7 Danaher DNA and RNA Oligonucleotide Synthesizers Sales by Geographic Area in 2024
11.1.8 Danaher DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
11.1.9 Danaher Recent Developments
11.2 K&A Labs GmbH
11.2.1 K&A Labs GmbH Corporation Information
11.2.2 K&A Labs GmbH Business Overview
11.2.3 K&A Labs GmbH DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.2.4 K&A Labs GmbH DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 K&A Labs GmbH DNA and RNA Oligonucleotide Synthesizers Sales by Product in 2024
11.2.6 K&A Labs GmbH DNA and RNA Oligonucleotide Synthesizers Sales by Application in 2024
11.2.7 K&A Labs GmbH DNA and RNA Oligonucleotide Synthesizers Sales by Geographic Area in 2024
11.2.8 K&A Labs GmbH DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
11.2.9 K&A Labs GmbH Recent Developments
11.3 Biolytic Lab Performance
11.3.1 Biolytic Lab Performance Corporation Information
11.3.2 Biolytic Lab Performance Business Overview
11.3.3 Biolytic Lab Performance DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.3.4 Biolytic Lab Performance DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Biolytic Lab Performance DNA and RNA Oligonucleotide Synthesizers Sales by Product in 2024
11.3.6 Biolytic Lab Performance DNA and RNA Oligonucleotide Synthesizers Sales by Application in 2024
11.3.7 Biolytic Lab Performance DNA and RNA Oligonucleotide Synthesizers Sales by Geographic Area in 2024
11.3.8 Biolytic Lab Performance DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
11.3.9 Biolytic Lab Performance Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.4.4 Thermo Fisher Scientific DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Thermo Fisher Scientific DNA and RNA Oligonucleotide Synthesizers Sales by Product in 2024
11.4.6 Thermo Fisher Scientific DNA and RNA Oligonucleotide Synthesizers Sales by Application in 2024
11.4.7 Thermo Fisher Scientific DNA and RNA Oligonucleotide Synthesizers Sales by Geographic Area in 2024
11.4.8 Thermo Fisher Scientific DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
11.4.9 Thermo Fisher Scientific Recent Developments
11.5 BioAutomation (LGC)
11.5.1 BioAutomation (LGC) Corporation Information
11.5.2 BioAutomation (LGC) Business Overview
11.5.3 BioAutomation (LGC) DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.5.4 BioAutomation (LGC) DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 BioAutomation (LGC) DNA and RNA Oligonucleotide Synthesizers Sales by Product in 2024
11.5.6 BioAutomation (LGC) DNA and RNA Oligonucleotide Synthesizers Sales by Application in 2024
11.5.7 BioAutomation (LGC) DNA and RNA Oligonucleotide Synthesizers Sales by Geographic Area in 2024
11.5.8 BioAutomation (LGC) DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
11.5.9 BioAutomation (LGC) Recent Developments
11.6 Polygen GmbH
11.6.1 Polygen GmbH Corporation Information
11.6.2 Polygen GmbH Business Overview
11.6.3 Polygen GmbH DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.6.4 Polygen GmbH DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Polygen GmbH Recent Developments
11.7 Telesis Bio
11.7.1 Telesis Bio Corporation Information
11.7.2 Telesis Bio Business Overview
11.7.3 Telesis Bio DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.7.4 Telesis Bio DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Telesis Bio Recent Developments
11.8 TAG Cop​​enhagen
11.8.1 TAG Cop​​enhagen Corporation Information
11.8.2 TAG Cop​​enhagen Business Overview
11.8.3 TAG Cop​​enhagen DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.8.4 TAG Cop​​enhagen DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 TAG Cop​​enhagen Recent Developments
11.9 CSBio
11.9.1 CSBio Corporation Information
11.9.2 CSBio Business Overview
11.9.3 CSBio DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.9.4 CSBio DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 CSBio Recent Developments
11.10 Kilobaser
11.10.1 Kilobaser Corporation Information
11.10.2 Kilobaser Business Overview
11.10.3 Kilobaser DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.10.4 Kilobaser DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Kilobaser Recent Developments
11.11 Jiangsu Lingkun Biotechnology
11.11.1 Jiangsu Lingkun Biotechnology Corporation Information
11.11.2 Jiangsu Lingkun Biotechnology Business Overview
11.11.3 Jiangsu Lingkun Biotechnology DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.11.4 Jiangsu Lingkun Biotechnology DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Jiangsu Lingkun Biotechnology Recent Developments
11.12 Jiangsu Nanyi DiNA Digital Technology
11.12.1 Jiangsu Nanyi DiNA Digital Technology Corporation Information
11.12.2 Jiangsu Nanyi DiNA Digital Technology Business Overview
11.12.3 Jiangsu Nanyi DiNA Digital Technology DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.12.4 Jiangsu Nanyi DiNA Digital Technology DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Jiangsu Nanyi DiNA Digital Technology Recent Developments
11.13 Shanghai Yibo Biotechnology
11.13.1 Shanghai Yibo Biotechnology Corporation Information
11.13.2 Shanghai Yibo Biotechnology Business Overview
11.13.3 Shanghai Yibo Biotechnology DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.13.4 Shanghai Yibo Biotechnology DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Shanghai Yibo Biotechnology Recent Developments
11.14 OligoMaker
11.14.1 OligoMaker Corporation Information
11.14.2 OligoMaker Business Overview
11.14.3 OligoMaker DNA and RNA Oligonucleotide Synthesizers Product Models, Descriptions and Specifications
11.14.4 OligoMaker DNA and RNA Oligonucleotide Synthesizers Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 OligoMaker Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 DNA and RNA Oligonucleotide Synthesizers Industry Chain
12.2 DNA and RNA Oligonucleotide Synthesizers Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 DNA and RNA Oligonucleotide Synthesizers Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 DNA and RNA Oligonucleotide Synthesizers Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 DNA and RNA Oligonucleotide Synthesizers Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global DNA and RNA Oligonucleotide Synthesizers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global DNA and RNA Oligonucleotide Synthesizers Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global DNA and RNA Oligonucleotide Synthesizers Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global DNA and RNA Oligonucleotide Synthesizers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global DNA and RNA Oligonucleotide Synthesizers Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global DNA and RNA Oligonucleotide Synthesizers Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global DNA and RNA Oligonucleotide Synthesizers Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global DNA and RNA Oligonucleotide Synthesizers Sales by Region (2020-2025) & (Units)
Table 8. Global DNA and RNA Oligonucleotide Synthesizers Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global DNA and RNA Oligonucleotide Synthesizers Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global DNA and RNA Oligonucleotide Synthesizers Sales Share by Manufacturers (2020-2025)
Table 12. Global DNA and RNA Oligonucleotide Synthesizers Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global DNA and RNA Oligonucleotide Synthesizers Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global DNA and RNA Oligonucleotide Synthesizers by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA and RNA Oligonucleotide Synthesizers as of 2024)
Table 16. Global DNA and RNA Oligonucleotide Synthesizers Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global DNA and RNA Oligonucleotide Synthesizers Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
Table 18. Key Manufacturers DNA and RNA Oligonucleotide Synthesizers Manufacturing Base and Headquarters
Table 19. Global DNA and RNA Oligonucleotide Synthesizers Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global DNA and RNA Oligonucleotide Synthesizers Sales by Type (2020-2025) & (Units)
Table 23. Global DNA and RNA Oligonucleotide Synthesizers Sales by Type (2026-2031) & (Units)
Table 24. Global DNA and RNA Oligonucleotide Synthesizers Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global DNA and RNA Oligonucleotide Synthesizers Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global DNA and RNA Oligonucleotide Synthesizers ASP by Type (2020-2031) & (K US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global DNA and RNA Oligonucleotide Synthesizers Sales by Application (2020-2025) & (Units)
Table 29. Global DNA and RNA Oligonucleotide Synthesizers Sales by Application (2026-2031) & (Units)
Table 30. DNA and RNA Oligonucleotide Synthesizers High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global DNA and RNA Oligonucleotide Synthesizers Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global DNA and RNA Oligonucleotide Synthesizers Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global DNA and RNA Oligonucleotide Synthesizers ASP by Application (2020-2031) & (K US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America DNA and RNA Oligonucleotide Synthesizers Growth Accelerators and Market Barriers
Table 37. North America DNA and RNA Oligonucleotide Synthesizers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America DNA and RNA Oligonucleotide Synthesizers Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe DNA and RNA Oligonucleotide Synthesizers Growth Accelerators and Market Barriers
Table 40. Europe DNA and RNA Oligonucleotide Synthesizers Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe DNA and RNA Oligonucleotide Synthesizers Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Growth Accelerators and Market Barriers
Table 45. Southeast Asia DNA and RNA Oligonucleotide Synthesizers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America DNA and RNA Oligonucleotide Synthesizers Investment Opportunities and Key Challenges
Table 47. Central and South America DNA and RNA Oligonucleotide Synthesizers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa DNA and RNA Oligonucleotide Synthesizers Investment Opportunities and Key Challenges
Table 49. Middle East and Africa DNA and RNA Oligonucleotide Synthesizers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Danaher Corporation Information
Table 51. Danaher Description and Major Businesses
Table 52. Danaher Product Models, Descriptions and Specifications
Table 53. Danaher Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 54. Danaher Sales Value Proportion by Product in 2024
Table 55. Danaher Sales Value Proportion by Application in 2024
Table 56. Danaher Sales Value Proportion by Geographic Area in 2024
Table 57. Danaher DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
Table 58. Danaher Recent Developments
Table 59. K&A Labs GmbH Corporation Information
Table 60. K&A Labs GmbH Description and Major Businesses
Table 61. K&A Labs GmbH Product Models, Descriptions and Specifications
Table 62. K&A Labs GmbH Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 63. K&A Labs GmbH Sales Value Proportion by Product in 2024
Table 64. K&A Labs GmbH Sales Value Proportion by Application in 2024
Table 65. K&A Labs GmbH Sales Value Proportion by Geographic Area in 2024
Table 66. K&A Labs GmbH DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
Table 67. K&A Labs GmbH Recent Developments
Table 68. Biolytic Lab Performance Corporation Information
Table 69. Biolytic Lab Performance Description and Major Businesses
Table 70. Biolytic Lab Performance Product Models, Descriptions and Specifications
Table 71. Biolytic Lab Performance Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 72. Biolytic Lab Performance Sales Value Proportion by Product in 2024
Table 73. Biolytic Lab Performance Sales Value Proportion by Application in 2024
Table 74. Biolytic Lab Performance Sales Value Proportion by Geographic Area in 2024
Table 75. Biolytic Lab Performance DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
Table 76. Biolytic Lab Performance Recent Developments
Table 77. Thermo Fisher Scientific Corporation Information
Table 78. Thermo Fisher Scientific Description and Major Businesses
Table 79. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 80. Thermo Fisher Scientific Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 81. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 82. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 83. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 84. Thermo Fisher Scientific DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
Table 85. Thermo Fisher Scientific Recent Developments
Table 86. BioAutomation (LGC) Corporation Information
Table 87. BioAutomation (LGC) Description and Major Businesses
Table 88. BioAutomation (LGC) Product Models, Descriptions and Specifications
Table 89. BioAutomation (LGC) Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 90. BioAutomation (LGC) Sales Value Proportion by Product in 2024
Table 91. BioAutomation (LGC) Sales Value Proportion by Application in 2024
Table 92. BioAutomation (LGC) Sales Value Proportion by Geographic Area in 2024
Table 93. BioAutomation (LGC) DNA and RNA Oligonucleotide Synthesizers SWOT Analysis
Table 94. BioAutomation (LGC) Recent Developments
Table 95. Polygen GmbH Corporation Information
Table 96. Polygen GmbH Description and Major Businesses
Table 97. Polygen GmbH Product Models, Descriptions and Specifications
Table 98. Polygen GmbH Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 99. Polygen GmbH Recent Developments
Table 100. Telesis Bio Corporation Information
Table 101. Telesis Bio Description and Major Businesses
Table 102. Telesis Bio Product Models, Descriptions and Specifications
Table 103. Telesis Bio Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 104. Telesis Bio Recent Developments
Table 105. TAG Cop​​enhagen Corporation Information
Table 106. TAG Cop​​enhagen Description and Major Businesses
Table 107. TAG Cop​​enhagen Product Models, Descriptions and Specifications
Table 108. TAG Cop​​enhagen Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 109. TAG Cop​​enhagen Recent Developments
Table 110. CSBio Corporation Information
Table 111. CSBio Description and Major Businesses
Table 112. CSBio Product Models, Descriptions and Specifications
Table 113. CSBio Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 114. CSBio Recent Developments
Table 115. Kilobaser Corporation Information
Table 116. Kilobaser Description and Major Businesses
Table 117. Kilobaser Product Models, Descriptions and Specifications
Table 118. Kilobaser Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 119. Kilobaser Recent Developments
Table 120. Jiangsu Lingkun Biotechnology Corporation Information
Table 121. Jiangsu Lingkun Biotechnology Description and Major Businesses
Table 122. Jiangsu Lingkun Biotechnology Product Models, Descriptions and Specifications
Table 123. Jiangsu Lingkun Biotechnology Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 124. Jiangsu Lingkun Biotechnology Recent Developments
Table 125. Jiangsu Nanyi DiNA Digital Technology Corporation Information
Table 126. Jiangsu Nanyi DiNA Digital Technology Description and Major Businesses
Table 127. Jiangsu Nanyi DiNA Digital Technology Product Models, Descriptions and Specifications
Table 128. Jiangsu Nanyi DiNA Digital Technology Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 129. Jiangsu Nanyi DiNA Digital Technology Recent Developments
Table 130. Shanghai Yibo Biotechnology Corporation Information
Table 131. Shanghai Yibo Biotechnology Description and Major Businesses
Table 132. Shanghai Yibo Biotechnology Product Models, Descriptions and Specifications
Table 133. Shanghai Yibo Biotechnology Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 134. Shanghai Yibo Biotechnology Recent Developments
Table 135. OligoMaker Corporation Information
Table 136. OligoMaker Description and Major Businesses
Table 137. OligoMaker Product Models, Descriptions and Specifications
Table 138. OligoMaker Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
Table 139. OligoMaker Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources


List of Figures
Figure 1. DNA and RNA Oligonucleotide Synthesizers Product Picture
Figure 2. Global DNA and RNA Oligonucleotide Synthesizers Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Solenoid Valve Pneumatic Drive Type Product Picture
Figure 4. Peristaltic Pump Drive Type Product Picture
Figure 5. Global DNA and RNA Oligonucleotide Synthesizers Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Biopharmaceutical Companies
Figure 7. API Manufacturing Companies
Figure 8. Research Institutions
Figure 9. Hospital Laboratory
Figure 10. Others
Figure 11. DNA and RNA Oligonucleotide Synthesizers Report Years Considered
Figure 12. Global DNA and RNA Oligonucleotide Synthesizers Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 14. Global DNA and RNA Oligonucleotide Synthesizers Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global DNA and RNA Oligonucleotide Synthesizers Revenue Market Share by Region (2020-2031)
Figure 16. Global DNA and RNA Oligonucleotide Synthesizers Sales (2020-2031) & (Units)
Figure 17. Global DNA and RNA Oligonucleotide Synthesizers Sales (CAGR) by Region (2020-2031) (Units)
Figure 18. Global DNA and RNA Oligonucleotide Synthesizers Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers DNA and RNA Oligonucleotide Synthesizers Sales Volume Market Share in 2024
Figure 20. Global DNA and RNA Oligonucleotide Synthesizers Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Solenoid Valve Pneumatic Drive Type Revenue Market Share by Manufacturer in 2024
Figure 23. Peristaltic Pump Drive Type Revenue Market Share by Manufacturer in 2024
Figure 24. Global DNA and RNA Oligonucleotide Synthesizers Sales Market Share by Type (2020-2031)
Figure 25. Global DNA and RNA Oligonucleotide Synthesizers Revenue Market Share by Type (2020-2031)
Figure 26. Global DNA and RNA Oligonucleotide Synthesizers Sales Market Share by Application (2020-2031)
Figure 27. Global DNA and RNA Oligonucleotide Synthesizers Revenue Market Share by Application (2020-2031)
Figure 28. North America DNA and RNA Oligonucleotide Synthesizers Sales YoY (2020-2031) & (Units)
Figure 29. North America DNA and RNA Oligonucleotide Synthesizers Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) in 2024
Figure 31. North America DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Type (2020- 2031)
Figure 32. North America DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Application (2020-2031)
Figure 34. North America DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 36. Canada DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 38. Europe DNA and RNA Oligonucleotide Synthesizers Sales YoY (2020-2031) & (Units)
Figure 39. Europe DNA and RNA Oligonucleotide Synthesizers Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) in 2024
Figure 41. Europe DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Type (2020-2031)
Figure 42. Europe DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Application (2020-2031)
Figure 44. Europe DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 46. France DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 48. Italy DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 49. Russia DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Sales YoY (2020-2031) & (Units)
Figure 51. Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Type (2020- 2031)
Figure 54. Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Application (2020-2031)
Figure 56. Asia-Pacific DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 58. Japan DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 61. India DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America DNA and RNA Oligonucleotide Synthesizers Sales YoY (2020-2031) & (Units)
Figure 63. Central and South America DNA and RNA Oligonucleotide Synthesizers Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Type (2021-2031)
Figure 66. Central and South America DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Application (2020-2031)
Figure 68. Central and South America DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa DNA and RNA Oligonucleotide Synthesizers Sales YoY (2020-2031) & (Units)
Figure 72. Middle East and Africa DNA and RNA Oligonucleotide Synthesizers Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Type (2021-2031)
Figure 75. South America DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa DNA and RNA Oligonucleotide Synthesizers Sales Volume (Units) by Application (2020-2031)
Figure 77. Middle East and Africa DNA and RNA Oligonucleotide Synthesizers Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa DNA and RNA Oligonucleotide Synthesizers Revenue (2020-2025) & (US$ Million)
Figure 82. DNA and RNA Oligonucleotide Synthesizers Industry Chain Mapping
Figure 83. Regional DNA and RNA Oligonucleotide Synthesizers Manufacturing Base Distribution (%)
Figure 84. Global DNA and RNA Oligonucleotide Synthesizers Production Market Share by Region (2020-2031)
Figure 85. DNA and RNA Oligonucleotide Synthesizers Production Process
Figure 86. Regional DNA and RNA Oligonucleotide Synthesizers Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies